Chair Rise and Step Ups on Cardiopulmonary Parameters Among Preserved Ejection Heart Failure Patients
- Conditions
- Heart Failure
- Interventions
- Other: Standard aerobic exercise i.e. low intensity walkingOther: Progressive lower limb activities (Chair rise and Step ups)
- Registration Number
- NCT05425160
- Lead Sponsor
- Riphah International University
- Brief Summary
To determine the effects of Chair Rise and Step ups on cardiopulmonary parameters among Preserved ejection Heart Failure Patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 52
- Diagnosed Preserved ejection Heart Failure Patients
- Both male and female
- Age > 60 years
- Preserved ejection fraction ≥ 45 %
- HF Duration ≥4 years
- End stage heart failure
- Acute coronary syndrome
- Functional status limited due to condition other than heart failure
- Inability to adhere to study protocols.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard aerobic exercise i.e. low intensity walking Standard aerobic exercise i.e. low intensity walking aerobic exercise i.e. low intensity walking Progressive lower limb activities (Chair rise and Step ups) Progressive lower limb activities (Chair rise and Step ups) Chair rise and Step ups Exercises
- Primary Outcome Measures
Name Time Method VO2 Max 6th week Changes from the baseline ;The maximum or optimum rate at which the heart, lungs and muscles can effectively use oxygen during exercise, used as a way of measuring a person's individual aerobic capacity.
Short Physical Performance Battery (SPPB) 6th week Changes from the baseline ; The SPPB is composed of 3 components-standing balance, gait, speed, and timed repeated chair rise-each scored on a scale from 0 to 4 and combined for a total score of 0 to 12. This protocol consisted of 3 types of progressive activities. Each type contains 2 to 4 tasks, performed in a single attempt. The protocol was performed in 30-minute sessions once a week. It was used to conduct chair rise activity only. Participant was asked to complete five chair stands and the time was noted and scored from 0-4 respectively.
6 Min Walk Distance (6MWT) 6th Week Changes from the baseline ; The 6 min walk test (6MWT) is a functional performance measure to examine the functional status of patients with heart and lung disease. This protocol has 1 item only. It was completed in less than 10 minutes. A 6MWT distance of 300 m was also recently found to be a significant predictor of all-cause mortality in a multivariate model examining predictors of clinical outcome in elderly patients with advanced HF. Patients were instructed to cover the greatest distance possible during the allotted time, at a self-determined walking speed, and were allowed to pause and rest when needed. The distance covered was measured by a body-borne pedometer with which the total number of steps taken during the 6MWT were used to calculate the 6MWT distance using the equation reported by Roul et al. (d ¼ y × 10 m/x; where d ¼ distance ambulated in m; y ¼ total number of steps during 6MWT; and x ¼ number of steps for each subject to cover 10 m
Oxygen Saturation 6th week Changes from the baseline ; The saturation of arterial blood with oxygen as measured by pulse oximetry, expressed as percentage.
Fatigue Assessment Scale (FAS) 6th Week Changes from the baseline ; The FAS is a 10-item scale evaluating symptoms of chronic fatigue. The FAS is a self-report, paperand-pencil measure requiring approximately 2 min for administration. The scale has been validated in a population of both male and female. Each item of the FAS is answered using a five-point, Likert-type scale ranging from 1 ("never") to 5 ("always"). Items 4 and 10 are reverse-scored. Total scores can range from 10, indicating the lowest level of fatigue, to 50, denoting the highest.
Minnesota Living with Heart Failure Questionnaire (MLHFQ) 6th week Changes from the baseline ; It is a 21 item paper self administered questionnaire. It aims to measure the extent to which HF prevents patients from living the way they would want to. The MLHFQ has been the most widely used instrument for evaluating HRQL in HF patients internationally. Five years ago, the MLHFQ was identified as the questionnaire with the best properties and even now it has the highest scores for reliability, and a good ability to both measure its objective (validity) and detect change over time
Heart Rate 6th week Changes from the baseline ; Heart rate was measured per minute through cardiac monitor
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Armed Forces Institute of Cardiology AFIC
🇵🇰Rawalpindi, Punjab, Pakistan